Jump to content

Ritipenem

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Innerstream (talk | contribs) at 21:50, 21 June 2022. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Ritipenem
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC10H12N2O6S
Molar mass288.27 g·mol−1
3D model (JSmol)
  • C[C@@H](O)[C@@H]1[C@H]2SC(=C(N2C1=O)C(=O)O)COC(=O)N
  • InChI=1S/C10H12N2O6S/c1-3(13)5-7(14)12-6(9(15)16)4(19-8(5)12)2-18-10(11)17/h3,5,8,13H,2H2,1H3,(H2,11,17)(H,15,16)/t3-,5+,8-/m1/s1
  • Key:IKQNRQOUOZJHTR-UWBRJAPDSA-N


Ritipenem is a penem class antimicrobial agent. Ritipenem is manufactured by Tanabe Seiyaku in the ritipenem acoxil prodrug form, which can be taken orally . It is not FDA approved in the United States as of 2008.

References

  • Eiland III EH, Gatlin D (October 2008). "Forecast of antibiotic development in an era of increasing bacterial resistance". Journal of Pharmacy Practice. 21 (5): 313–8. doi:10.1177/0897190008318499.